Clinical trial Recruiting at 1 site Phase2; Phase3 Interventional Ages 18 to 65

Clonidine added to ultrasound-guided rectus sheath block for outpatient umbilical hernia repair

Official title: Ultrasound-guided Rectus Abdominis Muscle Sheath Block in Outpatient Umbilical Hernioplasties: a Comparative Analysis of the Use of Clonidine as an Adjuvant - Prospective Randomized Clinical Trial

Run by Universidade Federal do Rio de Janeiro · NCT07062497 · Data updated 2026-11-12

This trial will test whether adding clonidine to an ultrasound-guided rectus sheath block reduces pain for adults having outpatient umbilical hernia repair.

More Pain, Postoperative trials

Quick facts

PhasePhase2; Phase3
Study typeInterventional
Ages18 Years to 65 Years
SexAll
Enrollment62 (estimated)
SponsorUniversidade Federal do Rio de Janeiro
Academic / other
Locations1 site (Rio de Janeiro, Rio de Janeiro)
StatusRecruiting
StartedJanuary 7, 2025
Main results expectedDecember 16, 2025
Study endsApril 30, 2026
Registry record updatedJuly 14, 2025
Trial IDNCT07062497 on ClinicalTrials.gov

Is this trial a fit for you?

Likely a good fit

Adults 18–65 years old with ASA physical status I or II scheduled for elective ambulatory umbilical hernia repair with a hernial defect ≤4 cm are ideal candidates.

Probably not a fit

Patients with larger hernias (>4 cm), contraindications to regional anesthesia, allergy to local anesthetics or clonidine, or ASA III+ conditions are unlikely to benefit or be eligible.

A plain-English reading of the study's rules. Only the study team can confirm whether you qualify.

What this trial studies

This is a prospective, randomized, double-blind trial comparing bilateral ultrasound-guided rectus sheath block (RSB) with and without clonidine as the sole anesthetic technique for elective ambulatory umbilical hernioplasty. Adults aged 18–65 with ASA I–II and hernia defects ≤4 cm are randomized to receive identical volumes of local anesthetic with or without 75 mcg clonidine per side under real-time ultrasound guidance. Sedation is given as needed and standard monitoring is used; outcomes include intraoperative and postoperative pain scores, recovery quality, opioid requirements, and side effects recorded up to 48 hours after surgery. The trial is conducted at the ambulatory surgery unit of the Policlínica Universitária Piquet Carneiro in Rio de Janeiro and uses patient questionnaires and clinical monitoring to compare groups.

Why it matters

Potential benefit: If successful, adding clonidine could improve pain control, reduce the need for opioids, and speed recovery after outpatient umbilical hernia repair.

How similar studies have gone: Previous studies have shown clonidine can prolong and improve analgesia when added to other peripheral nerve blocks and RSB has been used for abdominal wall analgesia, but using clonidine-containing RSB as the sole anesthetic for ambulatory umbilical hernioplasty is relatively limited in the literature.

Who can join: the full rules

Show full inclusion / exclusion criteria
Inclusion Criteria:

* Adults aged 18 to 65 years;
* Both male and female participants;
* ASA physical status I or II (American Society of Anesthesiologists classification);
* Scheduled for elective ambulatory umbilical hernia repair;
* Hernial defect size ≤ 4 cm (small to medium).

Exclusion Criteria:

* Refusal or inability to provide written informed consent;
* Cognitive or psychiatric disorders that impair comprehension or adherence to the study protocol;
* Known allergy or hypersensitivity to local anesthetics, clonidine, opioids, nonsteroidal anti-inflammatory drugs (NSAIDs), or other analgesics;
* Participation in another clinical trial within the previous 30 days;
* Missing data or loss to follow-up during postoperative assessments;
* Contraindications to regional anesthesia or known coagulopathy.

Where it's running

  • Policlinica Universitária Piquet Carneiro
    Rio de Janeiro, Rio de Janeiro, Brazil
    Recruiting

Study contacts

Similar studies

Other studies for the same condition or treatment. Recruiting studies are listed first.

How to take part

  1. Review the eligibility criteria above with your treating physician.
  2. Check the official listing on ClinicalTrials.gov for the latest contact details and recruitment status.
  3. Contact the study coordinator or principal investigator to ask for pre-screening. Pre-screening is free and never obligates you to enroll.
Last reviewed 2026-11-14 by the Find a Trial editorial team. Information on this page is for educational purposes and is not medical advice. Always consult qualified healthcare professionals about clinical trial participation.